Ofatumumab in combination with high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.

被引：0
|
作者：
Castro, Januario E. [1 ]
Choi, Michael Y. [1 ]
Carvajal, Tomas [1 ]
Li, Hongying [1 ]
James, Danelle Frances [1 ]
Messer, Karen [1 ]
Kipps, Thomas J. [1 ]
机构：
[1] UC San Diego Moores Canc Ctr, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7124
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients
    Montillo, Marco
    Tedeschi, Alessandra
    Gaidano, Gianluca
    Coscia, Marta
    Petrizzi, Valeria Belsito
    Orlandi, Ester
    Cascavilla, Nicola
    Ghia, Paolo
    Motta, Marina
    Gallamini, Andrea
    Frustaci, Anna Maria
    Rossi, Davide
    De Paoli, Lorenzo
    Nichelatti, Michele
    Morra, Enrica
    Massaia, Massimo
    [J]. HAEMATOLOGICA, 2014, 99 (09) : E159 - E161
  • [42] COSMIC, a phase II randomised study investigating the efficacy of standard or high-dose ofatumumab in combination with chemotherapy in patients with relapsed chronic lymphocytic leukaemia
    Allsup, David
    Howard, Dena
    Munir, Talha
    Hockaday, Anna
    Rawstron, Andy
    Collett, Laura
    McParland, Lucy
    Oughton, Jamie
    Bloor, Adrian
    Phillips, David
    Nathwani, Amit
    Shankara, Paneesha
    Turner, Deborah
    Hillmen, Peter
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 112 - 113
  • [43] A PHASE II RANDOMISED STUDY INVESTIGATING THE EFFICACY OF STANDARD OR HIGH-DOSE OFATUMUMAB IN COMBINATION WITH CHEMOTHERAPY IN RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA
    Allsup, D.
    Howard, D.
    Munir, T.
    Hockaday, A.
    Rawstron, A.
    Collett, L.
    McParland, L.
    Oughton, J.
    Bloor, A.
    Phillips, D.
    Nathwani, A.
    Shankara, P.
    Turner, D.
    Hillmen, P.
    [J]. HAEMATOLOGICA, 2017, 102 : 72 - 72
  • [44] OFATUMUMAB IN RELAPSE OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Garcia Sanchis, L.
    De Ona, R.
    Beneit, P.
    Diaz Lopez, A.
    Guzman Fernandez, M. R.
    Barez Garcia, A.
    Llopis Calatayud, I
    Sanchez Ramirez, J. M.
    Garcia Malo, M. D.
    Lopez Gomez, L.
    Sayas, M. J.
    Brea Atienza, J.
    Rios Herranz, E.
    Escudero Soto, A.
    Estevez, M.
    Solorzano, S.
    Iglesias, R.
    Montalban, C.
    Picon Roig, I
    De La Fuente, A.
    [J]. HAEMATOLOGICA, 2015, 100 : 184 - 184
  • [45] PRACTICAL MANAGEMENT AND CARE FOR PATIENTS TAKING VENETOCLAX FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA.
    Battiato, Kristen
    Paradis, Heather Brumbaugh
    Alton, Peggy
    Alter, Debbie
    Miale-Mayer, Donna
    Llerandi, Diane
    [J]. ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [46] High dose Rituximab in chronic lymphocytic leukemia.
    Jain, D
    Dutcher, JP
    Wiernik, PH
    [J]. BLOOD, 2003, 102 (11) : 359B - 360B
  • [47] Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) Combination for Patients with Chronic Lymphocytic Leukemia (CLL) - a Phase Ib/II Study
    Castro, Januario E.
    Amaya-Chanaga, Carlos I.
    Lujan, Juliana Velez
    Choi, Michael
    McCarthy, Colin
    Kipps, Thomas J.
    [J]. BLOOD, 2017, 130
  • [48] EFFICACY OF THE COMBINATION OF BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Zagoskina, T.
    Zotina, E.
    Ovsepyan, V.
    Shardakov, V.
    [J]. HAEMATOLOGICA, 2014, 99 : 591 - 591
  • [49] EFFICACY OF COMBINATION FLUDARABINE AND ALEMTUZUMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Zagoskina, T.
    Zotina, E.
    Malykh, O.
    [J]. HAEMATOLOGICA, 2012, 97 : 305 - 305
  • [50] Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
    Vitale, Candida
    Falchi, Lorenzo
    ten Hacken, Elisa
    Gao, Hui
    Shaim, Hila
    Van Roosbroeck, Katrien
    Calin, George
    O'Brien, Susan
    Faderl, Stefan
    Wang, Xuemei
    Wierda, William G.
    Rezvani, Katayoun
    Reuben, James M.
    Burger, Jan A.
    Keating, Michael J.
    Ferrajoli, Alessandra
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (10) : 2359 - 2367
12345